{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T13:35:57Z","timestamp":1785332157928,"version":"3.55.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.det.2010.03.012","type":"journal-article","created":{"date-parts":[[2010,5,28]],"date-time":"2010-05-28T06:01:09Z","timestamp":1275026469000},"page":"511-524","source":"Crossref","is-referenced-by-count":13,"title":["Biologic Drugs for the Treatment of Hidradenitis Suppurativa: An Evidence-Based Review"],"prefix":"10.1016","volume":"28","author":[{"given":"Fareesa","family":"Shuja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Stanley","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.det.2010.03.012_bib1","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1097\/00007611-199812000-00003","article-title":"Hidradenitis suppurativa","volume":"91","author":"Brown","year":"1998","journal-title":"South Med J"},{"key":"10.1016\/j.det.2010.03.012_bib2","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1396-0296.2004.04007.x","article-title":"Hidradenitis suppurativa: a review","volume":"17","author":"Wiseman","year":"2004","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.det.2010.03.012_bib3","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1745-7599.2007.00219.x","article-title":"Current understanding and management of hidradenitis suppurativa","volume":"19","author":"Krbec","year":"2007","journal-title":"J Am Acad Nurse Pract"},{"key":"10.1016\/j.det.2010.03.012_bib4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1742-481X.2006.00235.x","article-title":"Surgical treatment of hidradenitis suppurativa: case series and review of the literature","volume":"3","author":"Ather","year":"2006","journal-title":"Int Wound J"},{"key":"10.1016\/j.det.2010.03.012_bib5","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-4632.2004.02536.x","article-title":"\u201cHidradenitis suppurativa\u201d is acne inversa! An appeal to (finally) abandon a misnomer","volume":"44","author":"Sellheyer","year":"2005","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.det.2010.03.012_bib6","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/bjs.6569","article-title":"Hidradenitis suppurativa","volume":"96","author":"Buimer","year":"2009","journal-title":"Br J Surg"},{"key":"10.1016\/j.det.2010.03.012_bib7","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/jmg.22.5.367","article-title":"A family study of hidradenitis suppurativa","volume":"22","author":"Fitzsimmons","year":"1985","journal-title":"J Med Genet"},{"key":"10.1016\/j.det.2010.03.012_bib8","first-page":"1547","article-title":"Hidradenitis suppurativa: a treatment challenge","volume":"72","author":"Shah","year":"2005","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.det.2010.03.012_bib9","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0039-6109(02)00060-9","article-title":"Hidradenitis suppurativa","volume":"82","author":"Mitchell","year":"2002","journal-title":"Surg Clin North Am"},{"key":"10.1016\/j.det.2010.03.012_bib10","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1365-2133.2007.08372.x","article-title":"An open-label phase II study of the safety and efficacy of etanercept for the therapy of hidradenitis suppurativa","volume":"158","author":"Giamarellos-Bourboulis","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2010.03.012_bib11","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1365-2133.2005.07067.x","article-title":"Etanercept: effective in the management of hidradenitis suppurativa","volume":"154","author":"Cusack","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2010.03.012_bib12","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1684\/ejd.2008.0599","article-title":"Efficacy of adalimumab in recalcitrant hidradenitis suppurativa","volume":"19","author":"Sotiriou","year":"2009","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.det.2010.03.012_bib13","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1136\/bmj.323.7308.334","article-title":"A new system for grading recommendations in evidence based guidelines","volume":"323","author":"Harbour","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.det.2010.03.012_bib14","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.2165\/00003495-200868100-00003","article-title":"Evidence-based therapy for cutaneous sarcoidosis","volume":"68","author":"Doherty","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.det.2010.03.012_bib15","series-title":"Clinical dermatology","first-page":"68","article-title":"Psoriasis","author":"Weller","year":"2008"},{"key":"10.1016\/j.det.2010.03.012_bib16","first-page":"97","article-title":"Tumor necrosis factor alpha inhibitors for the treatment of dermatologic diseases","volume":"17","author":"Trent","year":"2005","journal-title":"Dermatol Nurs"},{"key":"10.1016\/j.det.2010.03.012_bib17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10227-004-0115-7","article-title":"A review of the use of infliximab to manage cutaneous dermatoses","volume":"8","author":"Gupta","year":"2004","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.det.2010.03.012_bib18","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1365-2125.2008.03263.x","article-title":"Adalimumab in dermatology","volume":"66","author":"Traczewski","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.det.2010.03.012_bib19","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2340\/00015555-0545","article-title":"Etanercept for the treatment of hidradenitis suppurativa","volume":"89","author":"Sotiriou","year":"2009","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.det.2010.03.012_bib20","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1111\/j.1468-3083.2008.02691.x","article-title":"Pachyonychia congenita and hidradenitis suppurativa: no response to infliximab therapy","volume":"22","author":"Pedraz","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.det.2010.03.012_bib21","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1600-0560.2008.01073.x","article-title":"What causes acne inversa (or hidradenitis suppurativa)?\u2014the debate continues","volume":"35","author":"Sellheyer","year":"2008","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.det.2010.03.012_bib22","first-page":"181","article-title":"Hidradenitis suppurativa managed with adalimumab","volume":"8","author":"Yamauchi","year":"2009","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.det.2010.03.012_bib23","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jaad.2006.01.024","article-title":"Treatment of coincident seronegative arthritis and hidradentis supprativa with adalimumab","volume":"55","author":"Scheinfeld","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2010.03.012_bib24","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1001\/archderm.142.9.1110","article-title":"The cutting edge. Severe hidradenitis suppurativa treated with adalimumab","volume":"142","author":"Moul","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2010.03.012_bib25","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","article-title":"Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials","volume":"295","author":"Bongartz","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.det.2010.03.012_bib26","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jaad.2007.07.032","article-title":"Efalizumab for the treatment of refractory hidradenitis suppurativa","volume":"57","author":"Strober","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2010.03.012_bib27","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1080\/09546630902984596","article-title":"Efalizumab discontinuation: a practical strategy","volume":"20","author":"Pugashetti","year":"2009","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.det.2010.03.012_bib28","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jaad.2008.11.898","article-title":"A prospective clinical trial of open-label etanercept for the treatment of hidradenitis suppurativa","volume":"60","author":"Lee","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2010.03.012_bib29","first-page":"1010","article-title":"Case reports: treatment of atypical hidradenitis suppurativa with the tumor necrosis factor receptor-Fc fusion protein etanercept","volume":"5","author":"Henderson","year":"2006","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.det.2010.03.012_bib30","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1111\/j.1468-3083.2008.02617.x","article-title":"Long-term efficacy of etanercept in hidradenitis suppurativa","volume":"22","author":"Zangrilli","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.det.2010.03.012_bib31","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/sj.eye.6703100","article-title":"Bilateral Candida chorioretinitis following etanercept treatment for hidradenitis suppurativa","volume":"22","author":"Arriola-Villalobos","year":"2008","journal-title":"Eye"},{"key":"10.1016\/j.det.2010.03.012_bib32","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s10227-005-0110-7","article-title":"Off-label dermatologic uses of anti-TNF-\u03b1 therapies","volume":"9","author":"Alexis","year":"2005","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.det.2010.03.012_bib33","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1001\/archderm.139.12.1540","article-title":"Severe hidradenitis suppurativa treated with infliximab infusion","volume":"139","author":"Adams","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2010.03.012_bib34","first-page":"CS14","article-title":"Experiences with a long-term treatment of a massive gluteal acne inversa with infliximab in Crohn's disease","volume":"15","author":"Goertz","year":"2009","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.det.2010.03.012_bib35","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1111\/j.1572-0241.2002.05950.x","article-title":"Axillary hidradenitis suppurativa successfully treated with infliximab in a Crohn's disease patient","volume":"97","author":"Katsanos","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.det.2010.03.012_bib36","doi-asserted-by":"crossref","first-page":"S275","DOI":"10.1016\/S0190-9622(03)01132-0","article-title":"Infliximab for the treatment of hidradenitis suppurativa","volume":"49","author":"Lebwohl","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2010.03.012_bib37","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/00054725-200111000-00008","article-title":"Hidradenitis suppurativa and Crohn's disease: response to treatment with infliximab","volume":"7","author":"Martinez","year":"2001","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.det.2010.03.012_bib38","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1016\/j.ejim.2007.11.014","article-title":"Amyloidosis secondary to hidradenitis suppurativa. Exceptional response to infliximab","volume":"19","author":"Montes-Romero","year":"2008","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.det.2010.03.012_bib39","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1080\/09546630410024547","article-title":"Treatment of hidradenitis suppurativa with infliximab in a patient with Crohn's disease","volume":"16","author":"Rosi","year":"2005","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.det.2010.03.012_bib40","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/j.1365-2133.2006.07528.x","article-title":"Long-term infliximab for severe hidradenitis suppurativa","volume":"155","author":"Thielen","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2010.03.012_bib41","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1111\/j.1365-4632.2007.03293.x","article-title":"Is there a role for infliximab in the current therapy of hidradenitis suppurativa? A report of three treated cases","volume":"46","author":"Moschella","year":"2007","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.det.2010.03.012_bib42","doi-asserted-by":"crossref","first-page":"274","DOI":"10.2340\/00015555-0397","article-title":"Acne inversa treated with infliximab: different outcomes in 2 patients","volume":"88","author":"Antonucci","year":"2008","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.det.2010.03.012_bib43","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1111\/j.1365-2133.2003.05663.x","article-title":"Infliximab for hidradenitis suppurativa","volume":"149","author":"Sullivan","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2010.03.012_bib44","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jaad.2006.07.027","article-title":"Infliximab for severe hidradenitis suppurativa: transient clinical efficacy in 7 consecutive patients","volume":"56","author":"Fardet","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2010.03.012_bib45","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1365-2230.2006.02272.x","article-title":"Variable response of hidradenitis suppurativa to infliximab in four patients","volume":"32","author":"Usmani","year":"2007","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.det.2010.03.012_bib46","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000102032","article-title":"Infliximab for the treatment of hidradenitis suppurativa","volume":"215","author":"Fern\u00e1ndez-Vozmediano","year":"2007","journal-title":"Dermatology"},{"key":"10.1016\/j.det.2010.03.012_bib47","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0001-7310(07)70076-5","volume":"98","author":"Pedraz","year":"2007","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.det.2010.03.012_bib48","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1365-2133.2007.08332.x","article-title":"Long-term efficacy of a single course of infliximab in hidradenitis suppurativa","volume":"158","author":"Mekkes","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2010.03.012_bib49","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/j.1365-2133.2008.08735.x","article-title":"Hidradenitis suppurativa: are tumour necrosis factor-alpha blockers the ultimate alternative?","volume":"159","author":"Brunasso","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2010.03.012_bib50","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1365-2133.2008.08728.x","article-title":"Review and expert opinion on prevention and treatment of infliximab-related infusion reactions","volume":"159","author":"Lecluse","year":"2008","journal-title":"Br J Dermatol"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863510000537?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863510000537?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T03:02:45Z","timestamp":1711508565000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863510000537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0733863510000537"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2010.03.012","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}